Literature DB >> 1355486

Evaluation of different staging systems for Kaposi's sarcoma in HIV-infected patients.

A Antinori1, I Izzi, A Ammassari, G Camilli, R Murri, E Tamburrini.   

Abstract

The records of 49 consecutive AIDS patients with Kaposi's sarcoma were analysed retrospectively to assess the prognostic value of the four staging systems proposed for epidemic Kaposi's sarcoma. The classifications by Krigel and Mitsuyasu do not describe exactly the characteristics of the disease, and do not give enough information on survival. Our study confirms that CD4+ cell depletion, systemic symptoms and opportunistic infections at diagnosis are the major prognostic factors and influence survival to a great extent, as shown by Krown and Chachoua.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1355486     DOI： 10.1007/bf01211811

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN： 0171-5216            Impact factor:   4.553


  10 in total

1.  Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee.

Authors:  S E Krown; C Metroka; J C Wernz
Journal:  J Clin Oncol       Date:  1989-09       Impact factor: 44.544

2.  Prognostically significant classification of immune changes in AIDS with Kaposi's sarcoma.

Authors:  J Taylor; R Afrasiabi; J L Fahey; E Korns; M Weaver; R Mitsuysau
Journal:  Blood       Date:  1986-03       Impact factor: 22.113

3.  Heterogeneity of epidemic Kaposi's sarcoma. Implications for therapy.

Authors:  R T Mitsuyasu; J M Taylor; J Glaspy; J L Fahey
Journal:  Cancer       Date:  1986-04-15       Impact factor: 6.860

4.  Kaposi's sarcoma in Uganda: a clinico-pathological study.

Authors:  J F Taylor; A C Templeton; C L Vogel; J L Ziegler; S K Kyalwazi
Journal:  Int J Cancer       Date:  1971-07-15       Impact factor: 7.396

5.  Kaposi's sarcoma in homosexual men-a report of eight cases.

Authors:  K B Hymes; T Cheung; J B Greene; N S Prose; A Marcus; H Ballard; D C William; L J Laubenstein
Journal:  Lancet       Date:  1981-09-19       Impact factor: 79.321

6.  Biology and therapy of Kaposi's sarcoma.

Authors:  R T Mitsuyasu; J E Groopman
Journal:  Semin Oncol       Date:  1984-03       Impact factor: 4.929

7.  Prognostic factors and staging classification of patients with epidemic Kaposi's sarcoma.

Authors:  A Chachoua; R Krigel; F Lafleur; R Ostreicher; M Speer; L Laubenstein; J Wernz; P Rubenstein; E Zang; A Friedman-Kien
Journal:  J Clin Oncol       Date:  1989-06       Impact factor: 44.544

8.  Disseminated Kaposi's sarcoma in homosexual men.

Authors:  A E Friedman-Kien; L J Laubenstein; P Rubinstein; E Buimovici-Klein; M Marmor; R Stahl; I Spigland; K S Kim; S Zolla-Pazner
Journal:  Ann Intern Med       Date:  1982-06       Impact factor: 25.391

9.  Kaposi's sarcoma: a new staging classification.

Authors:  R L Krigel; L J Laubenstein; F M Muggia
Journal:  Cancer Treat Rep       Date:  1983-06

10.  Clinical variants and staging of Kaposi's sarcoma.

Authors:  R T Mitsuyasu
Journal:  Semin Oncol       Date:  1987-06       Impact factor: 4.929
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.